EGFR and non-small cell lung carcinoma: Epidermal Growth Factor Receptor (EGFR) sensitizing mutations occurring in exon 18–21, firstly described in NSCLC in 2004 [3], were reported with higher prevalence in the Asian population (40–60%) than the Caucasian one (10–20%), as well as in female, younger, and never or light smokers [4].